Eli Lilly & Co. (LLY)

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

Industry: Pharmaceutical Preparations (SIC 2834)

Market region: US

Address: Lilly Corporate Ctr, Drop Code 1094, Indianapolis, IN, 46285

Market capitalization

1.26 trillion USD (1,262,666,711,244 USD)

Listing date

07/09/1970

Weighted shares outstanding

890,745,031

Share class shares outstanding

941,357,065

https://www.lilly.com